N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models

被引:7
|
作者
Cieslak, Anna [1 ,2 ]
Trottier, Jocelyn [1 ,2 ]
Verreault, Melanie [1 ,2 ]
Milkiewicz, Piotr [3 ,4 ]
Vohl, Marie-Claude [5 ,6 ]
Barbier, Olivier [1 ,2 ]
机构
[1] Laval Univ, CHU Quebec Res Ctr, Lab Mol Pharmacol, Quebec City, PQ, Canada
[2] Laval Univ, Fac Pharm, Quebec City, PQ, Canada
[3] Med Univ Warsaw, Liver & Internal Med, Warsaw, Poland
[4] Pomeranian Med Univ, Translat Med Grp, Szczecin, Poland
[5] Laval Univ, Inst Nutr & Funct Foods INAF, Quebec City, PQ, Canada
[6] Laval Univ, CHU Quebec Res Ctr, Quebec City, PQ, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
PRIMARY SCLEROSING CHOLANGITIS; PRIMARY BILIARY-CIRRHOSIS; RAT HEPATOCYTES; LIVER; APOPTOSIS; EXPRESSION; PHYSIOLOGY; RECEPTORS; CHEMISTRY; INJURY;
D O I
10.1155/2018/6031074
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cholestasis is characterized by the accumulation of toxic bile acids (BAs) in liver cells. The present study aimed to evaluate the effects of n-3 polyunsaturated fatty acids (n-3 PUFAs), such as docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids, on BA homeostasis and toxicity in human cell models. The effects of EPA and/or DHA on the expression of genes involved in the maintenance of BA homeostasis were analyzed in human hepatoma (HepG2) and colon carcinoma (Caco-2) cells, as well as in primary culture of human intestinal (InEpC) and renal (RPTEC) cells. Extracellular BA species were quantified in culture media using LC-MS/MS. BA-induced toxicity was evaluated using caspase-3 and flow cytometry assays. Gene expression analyses of HepG2 cells reveal that n-3 PUFAs reduce the expression of genes involved in BA synthesis (CYP7A1, CYP27A1) and uptake (NTCP), while activating genes encoding metabolic enzymes (SULT2A1) and excretion transporters (MRP2, MRP3). N-3 PUFAs also generate a less toxic BA pool and prevent the BA-dependent activation of apoptosis in HepG2 cells. Conclusion. The present study reveals that n-3 PUFAs stimulate BA detoxification.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] N-3 polyunsaturated fatty acids and brain aging
    Nyakas, C.
    Hogyes, E.
    Kacsandi, A.
    Felszeghy, K.
    Mehra, R. D.
    Luiten, P. G. M.
    ACTA PHYSIOLOGICA HUNGARICA, 2010, 97 (04) : 465 - 466
  • [22] n-3 polyunsaturated fatty acids and coronary thrombosis
    Kristensen, SD
    Iversen, AMB
    Schmidt, EB
    LIPIDS, 2001, 36 : S79 - S82
  • [23] Heterogeneity in the response to n-3 polyunsaturated fatty acids
    Shaikh, Saame Raza
    Bazinet, Richard P.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2023, 26 (03): : 284 - 287
  • [24] The benefits and risks of n-3 polyunsaturated fatty acids
    Takahata, K
    Monobe, K
    Tada, M
    Weber, PC
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1998, 62 (11) : 2079 - 2085
  • [25] N-3 polyunsaturated fatty acids for cardiovascular risk
    Goff, Zackary D.
    Nissen, Steven E.
    CURRENT OPINION IN CARDIOLOGY, 2022, 37 (04) : 356 - 363
  • [26] N-3 polyunsaturated fatty acids and allergic disease
    Prescott, SL
    Calder, PC
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (02): : 123 - 129
  • [27] n-3 polyunsaturated fatty acids and insulin secretion
    Wang, Xiaofeng
    Chan, Catherine B.
    JOURNAL OF ENDOCRINOLOGY, 2015, 224 (03) : R97 - R106
  • [28] N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
    Joffre, Corinne
    Rey, Charlotte
    Laye, Sophie
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [29] ESSENTIALITY OF N-3 POLYUNSATURATED FATTY-ACIDS
    SINGER, P
    AKTUELLE ERNAHRUNGSMEDIZIN, 1989, 14 (06): : 293 - 303
  • [30] n-3 polyunsaturated fatty acids in the treatment of schizophrenia
    Peet, M
    Mellor, J
    FOURTH INTERNATIONAL CONGRESS ON ESSENTIAL FATTY ACIDS AND EICOSANOIDS, 1998, : 354 - 357